|Bid||0.00000 x 0|
|Ask||0.00000 x 0|
|Day's Range||0.00000 - 0.00000|
|52 Week Range|
|Beta (3Y Monthly)||-0.76|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 29, 2018 - Apr 2, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
BOCA RATON, FL / ACCESSWIRE / March 30, 2018 / Vycor Medical, Inc. (Vycor) (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, reported financial results for the year ...
Vycor Medical, Inc. (VYCO) had previously announced in October 2017 to its customer base the release of its enhanced VBAS, which it would be slowly rolling out over the course of this year as it ran down its inventory of the current VBAS. Following surgeon feedback Vycor has decided that it will from now be shipping only the enhanced model VBAS across the complete main range of 12 VBAS sizes. As previously announced the Company has been working on improving how its VBAS integrates with the most common Image Guidance System ("IGS") pointers on the market.
Categories: Yahoo FinanceGet free summary analysis Vycor Medical, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Vycor Medical, Inc. – Alphatec Holdings, Inc., NuVasive, Inc., Xtant Medical Holdings, Inc., CAS Medical Systems, Inc. and TransEnterix, Inc. (ATEC-US, NUVA-US, XTNT-US, CASM-US and TRXC-US) that have ... Read more (Read more...)